In vitro activity of teichomycin compared with those of other antibiotics
about
Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patientsProtein binding and serum bactericidal activities of vancomycin and teicoplanin.Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery.Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplaninAntibacterial activity of the new glycopeptide antibiotic SKF104662.Teicoplanin in the treatment of gram-positive-bacterial endocarditis.Management of listeriosis.Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations.Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locationsA clinical view of vancomycin in 1990.In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats.Population pharmacokinetics of teicoplanin in patients with endocarditis.Comparison of the agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of teicoplanin MICs.Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.Evaluation of teicoplanin and vancomycin disk susceptibility tests.Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.Therapeutic update on glycopeptide and lipopeptide antibiotics.Glycopeptide antibiotics.Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.Synergistic activity between vancomycin or teicoplanin and gentamicin or tobramycin against pathogenic diphtheroidsPharmacokinetics of teicoplanin in pediatric patients.Determination of teicoplanin concentrations in serum by high-pressure liquid chromatography.In vitro activity and human pharmacokinetics of teicoplanin.Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers.Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.Characterisation of the selective binding of antibiotics vancomycin and teicoplanin by the VanS receptor regulating type A vancomycin resistance in the enterococci.Teicoplanin or vancomycin in the treatment of gram-positive infections?Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections.Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers.Efficacy of teicoplanin, administered in two different regimens, in the treatment of experimental endocarditis due to Enterococcus faecalis.Activity of teicoplanin against coagulase-negative staphylococci isolated from patients undergoing continuous peritoneal dialysis.Methicillin-resistant Staphylococcus aureus: clinical and laboratory features.
P2860
Q33742289-7DDAB737-5E0B-49CC-8DB9-86E2A7BECE57Q35117545-472B7DC2-4C47-4D4D-8CF9-485877867211Q35272273-987C6AB6-9F11-4E81-AE15-AAA1951E859CQ35285763-DCCC17F9-1C19-4F6D-BA2F-7EE76ED4809BQ35328150-61D3FB16-925E-492D-B3B1-CA4D8CA91413Q35344121-27FE9EA3-F29F-4000-B5F0-E6ABC41590F1Q35374228-B32EEBC6-33FB-4871-9A50-B329F5F34CD3Q35536476-403D9B03-6607-454F-9565-8185E9BB629FQ35539120-AA8A6F00-EE9E-458E-9F80-35390331A5F2Q35572334-FEAEF0E9-BE58-4C9A-B44B-DFAE98D2EF72Q35643064-9B0C8739-4D38-4CAE-A2F7-EE7568DC43E5Q35825738-05D9E0D7-C9CB-41E6-8080-97FDD632F166Q35862707-93F2E7E8-E489-4D8A-A54C-BD573CE11200Q36792782-014253F1-98F0-450F-8B4D-627546A70B1DQ37175723-AD3CE613-C744-402A-AC3F-FE12D75D4473Q37180779-AF43E809-5A4C-402F-B1BD-40A861FDE75BQ37201082-8DEAD331-CC29-4300-AD19-A8D6A40423B8Q37219814-22C036ED-3E1B-404E-97EA-514D852C5419Q39291062-D7FBAB9E-7E6D-4EBE-9430-1E3579B9254EQ39637662-3D3B4CED-1887-47CD-AC31-C99FEB45D1B5Q39815914-BAC7E7F3-2381-4A55-BD59-48BA44C4FB1AQ39817907-13672E3E-8885-49C5-B67A-56171E280A30Q39818673-B93BCDD5-A2D4-426D-8FA7-6561311CFB67Q39828553-B9448D55-3CC3-4E79-AA32-8B5C4B669C3DQ39849439-5C996943-6E76-4B78-A1DF-A4E353864D1FQ39870962-44AEFD45-A441-4AE2-8347-43387E19180FQ40085890-0A2E6E88-411A-4B7F-BAD8-8EACF68BDD45Q40210054-BEA1A06C-5901-46ED-89FF-D8CE7AB3DCB0Q40541603-4D6EA384-D1C4-4159-9019-BAB27F6E6E9DQ41282587-AEB6DDBF-3EC8-4C91-91FE-FDDB55C71616Q44297842-7E2E8B5E-3D77-4AAE-818A-DE4EB99FD893Q45158747-82CCBB1E-CE2D-44A0-9393-944F43F3E4DCQ54433710-74780F7C-6CD3-4CCB-8300-C425A1E8B331Q54442143-A8050830-1229-4DE1-A654-8D991451AE9F
P2860
In vitro activity of teichomycin compared with those of other antibiotics
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
In vitro activity of teichomycin compared with those of other antibiotics
@en
type
label
In vitro activity of teichomycin compared with those of other antibiotics
@en
prefLabel
In vitro activity of teichomycin compared with those of other antibiotics
@en
P2860
P356
P1476
In vitro activity of teichomycin compared with those of other antibiotics
@en
P2093
P2860
P304
P356
10.1128/AAC.24.3.425
P407
P577
1983-09-01T00:00:00Z